CSPC Pharmaceutical Group (CSPCY) Stock Price, News & Analysis

Company Overview

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacture and sale of medicines and pharmaceutical ingredients. The company offers prescription and over-the-counter products across several therapeutic areas, including cardiovascular and cerebrovascular conditions, oncology, central nervous system disorders, infectious diseases and gastrointestinal conditions.

Its product portfolio includes innovative medicines, generic drugs, traditional Chinese medicines and active pharmaceutical ingredients. CSPC is known for products such as NBP (butylphthalide), used in the treatment of ischemic stroke, as well as a range of injectable and oral formulations. The company also produces bulk pharmaceutical products, including vitamin C and other chemical ingredients used by the pharmaceutical industry.

Headquartered in Shijiazhuang, Hebei Province, CSPC serves the Chinese healthcare market and exports selected products to international markets. The group operates through multiple pharmaceutical subsidiaries and has historically emphasized drug research, product development and the expansion of its innovative-medicine business. CSPC Pharmaceutical Group is listed in Hong Kong, and its American depositary receipts trade in the over-the-counter market under the symbol CSPCY.

Key Stats

• Today's Range: C$4.91 to C$4.91
• 50-Day Range: C$4.21 to C$5.21
• 52-Week Range: C$3.26 to C$5.46
• Volume: 4,044 shs
• Average Volume: 3,075 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CSPCY
• CIK: N/A
• Web: www.cspc.com.hk
• Phone: 86-31-1870-37015
• Fax: N/A
• Employees: 19,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A